It's an in-vitro finding - cells in a dish, not people
HLA-DR reference range is under 25 %, however, we established a cut off level of 35 % to high level of expression, which was not achieved by all patients
PlexusDx serves all 50 states with no insurance required and HSA/FSA eligibility, making it feasible to maintain treatment indefinitely
The formulation lacks the brand-name multi-dose pen device and pre-measured cartridge system, requiring patients to draw doses from multi-dose vials using insulin syringes, but the pharmacological mechanism remains identical
Immune hydrops constitute approximately 10% of cases and is treatable with the use of an anti-D immunoglobulin if detected early on
With the importance of disease-modifying therapies for an eventual cure for Parkinsons, there is a clear need for further initiatives that will facilitate the progression of drugs through the clinical trial pipeline and into subsequent phases of testing